Esomeprazole and omeprazole may enhance the serum concentrations of benzodiazepines (by means of CYP2C19 inhibition) bringing about increased adverse effects including drowsiness, although the scientific relevance is very low in the majority of individuals – check the individual for adverse effects (e.If individual cannot resume their common oral

Esomeprazole and omeprazole may boost the serum concentrations of benzodiazepines (via CYP2C19 inhibition) leading to improved adverse effects for instance drowsiness, Even though the clinical relevance is reduced in most people – watch the client for adverse effects (e.If affected individual are not able to resume their usual oral medication put